Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.

Kline, J; Pollyea, D A; Stock, W; Artz, A; Rich, E; Godley, L; Zimmerman, T; Thompson, K; Pursell, K; Larson, R A; van Besien, K

Kline, J; Pollyea, D A; Stock, W; Artz, A; Rich, E; Godley, L; Zimmerman, T; Thompson, K; Pursell, K; Larson, R A; van Besien, K.

Affiliation

Kline J; Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.

Bone Marrow Transplant ; 37(3): 307-10, 2006 Feb.

Article in En | MEDLINE | ID: mdl-16400339

Subject(s)

Acyclovir/analogs & derivatives; Antibodies, Monoclonal/administration & dosage; Antibodies, Neoplasm/administration & dosage; Antineoplastic Agents/administration & dosage; Antiviral Agents/administration & dosage; Bone Marrow Transplantation; Cytomegalovirus Infections/prevention & control; Ganciclovir/administration & dosage; Transplantation Conditioning; Valine/analogs & derivatives; Acyclovir/administration & dosage; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Bone Marrow Transplantation/adverse effects; Cytomegalovirus Infections/etiology; Female; Hematologic Neoplasms/complications; Hematologic Neoplasms/therapy; Humans; Incidence; Male; Middle Aged; Transplantation, Homologous; Valacyclovir; Valine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Antiviral Agents / Valine / Acyclovir / Ganciclovir / Bone Marrow Transplantation / Cytomegalovirus Infections / Transplantation Conditioning / Antibodies, Monoclonal / Antibodies, Neoplasm / Antineoplastic Agents Type of study: Etiology_studies / Incidence_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Year: 2006 Document type: Article

Search on Google

XML

PubMed Links